Swiss Global Pharma
Home Products Services Contact
HomeProductsServicesContact
Swiss Global Pharma
SWISS PHARMACEUTICAL WHOLESALER . IMPORT AND EXPORT OF MEDICINAL PRODUCTS . INTERNATIONAL PHARMACEUTICAL TRADING

Alecensa

Alecensa (alectinib) is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive, metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib.

Productsparisiva—25 February 2019
Facebook0 Twitter LinkedIn0 Reddit Tumblr Pinterest0
Previous

Abraxane

Productsparisiva—25 February 2019
Next

Darzalex

Productsparisiva—25 February 2019
 

©2023 Swiss Global Pharma - Via Geretta 2 - 6900 Lugano (Switzerland) - T. 004191 994 12 58 - info@swissglobalpharma.com - Data Protection Statement

 

Partner:

sandozLogo.png
Swiss Global Pharma
2 Via Geretta,
Paradiso, TI, 6900,
Switzerland
004191 994 11 58 info@swissglobalpharma.com